Santa Cruz de Tenerife, May 18, 2021.- The Hospiten Group stresses the importance of early diagnosis in Inflammatory Bowel Disease (IBD) which improves the quality of life of chronic patients affected by this type of condition, which includes Crohn's Disease and Ulcerative Colitis.
As explained by Dr. Maria del Carmen Dorta, of the Hospiten Gastrointestinal Service, numerous experts agree that certain individuals have a genetic predisposition that may trigger this intestinal condition and may depend on the person's lifestyle, involving diet, infection or the environment in which a patient lives, among other aspects.
She adds that the way in which Inflammatory Bowel Disease occurs in adults is very clear, beginning with diarrhea, the presence of blood or mucus in stools, loss of weight and appetite, fatigue and abdominal pain, while in the case of children, the condition is usually identified by a sudden loss of weight, accompanied by diarrhea and abdominal pain.
It is estimated that in Spain, approximately 100,000 people suffer from Inflammatory Bowel Disease.
Dr. Maria del Carmen Dorta explains that diagnosing the disease requires testing both blood and feces to rule out further bacterial infections, in addition to an ileocolonoscopy with biopsy, which is fundamental to confirming the diagnosis, identifying the degree of intestinal inflammation, and evaluating the extent of the disease.
The most appropriate treatment for each patient is established on the basis of a number of factors like the type of disease, how aggressive it is, which may condition the response of the patient to medication, or the presence of associated extraintestinal manifestations.
Studies carried out in recent years support the importance of intestinal microbiota, the set of bacteria that live in the intestine, as a trigger for the disease.
About the Hospiten Group
The Hospiten Group is an international healthcare network with 50 years of experience committed to providing the highest quality service, which has twenty private medical-hospital centers in Spain, the Dominican Republic, Mexico, Jamaica and Panama, in addition to more than a hundred outpatient consultation offices under the brand name Clinic Assist. The group is chaired by Dr. Pedro Luis Cobiella and attends more than 1,900,000 patients from all over the world every year with a workforce of more than 5,000 people.